Literature DB >> 20642575

The role of filaggrin in the atopic diathesis.

G M O'Regan1, A D Irvine.   

Abstract

Atopic dermatitis (AD) is an inflammatory disease characterized by pruritic skin lesions, immunodysregulation, disrupted epidermal barrier function and IgE-mediated sensitization to food and environmental allergens. Identification of the aetiology of AD has become increasingly a priority, as it is clear that the disease burden exceeds AD alone, with many children suffering severe, multi-system and occasionally life-threatening allergic disease. Previous approaches to understanding AD have centred on mechanisms in the adaptive immune system, often with an emphasis on the Th1-Th2 paradigm. Recently, the conceptual focus has increasingly shifted to include a primary defect in the epithelial barrier as a threshold event in moderate-to-severe AD. Familial aggregation of the disease is well established through many family studies of AD, asthma and allergic rhinitis, suggesting a significant heritable component. The identification of loss-of-function mutations in the filaggrin (FLG) gene, whose product is a key structural protein in the outermost layer of the epidermis in up to 50% of patients with AD, provides a significant insight into explaining disease initiation and points to a complex secondary interplay of environmental and immunological sequelae once barrier disruption is established. The elucidation of the environmental, genetic and immunobiological modifiers of this structural molecule may also direct our understanding of the pathomechanisms and endotypes central to the atopic diathesis. The recent identification of a murine model for FLG-AD, with the detection of a homozygous frame-shift mutation in the Flg gene in flaky-tail (ft/ft) mice, stands to rapidly accelerate our understanding of mechanisms and therapeutic intervention points in AD. Refining the molecular understanding of AD and its subtypes will allow for specific diagnostic, treatment and ultimately, preventative algorithms, and has opened an exciting new world of investigative challenges and collaborations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20642575     DOI: 10.1111/j.1365-2222.2010.03522.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  27 in total

1.  The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin.

Authors:  James Q Del Rosso; Jacqueline Levin
Journal:  J Clin Aesthet Dermatol       Date:  2011-09

Review 2.  Food introduction and allergy prevention in infants.

Authors:  Elissa M Abrams; Allan B Becker
Journal:  CMAJ       Date:  2015-10-19       Impact factor: 8.262

3.  Pathways to managing atopic dermatitis: consensus from the experts.

Authors:  Mark G Lebwohl; James Q Del Rosso; William Abramovits; Brian Berman; David E Cohen; Emma Guttman; Anthony J Mancini; Lawrence A Schachner
Journal:  J Clin Aesthet Dermatol       Date:  2013-07

4.  Allergic sensitization and filaggrin variants predispose to the comorbidity of eczema, asthma, and rhinitis: results from the Isle of Wight birth cohort.

Authors:  A H Ziyab; W Karmaus; H Zhang; J W Holloway; S E Steck; S Ewart; S H Arshad
Journal:  Clin Exp Allergy       Date:  2014-09       Impact factor: 5.018

5.  Association of filaggrin variants with asthma and rhinitis: is eczema or allergic sensitization status an effect modifier?

Authors:  Ali H Ziyab; Wilfried Karmaus; Hongmei Zhang; John W Holloway; Susan E Steck; Susan Ewart; Syed Hasan Arshad
Journal:  Int Arch Allergy Immunol       Date:  2014-09-23       Impact factor: 2.749

Review 6.  Deconstructing the skin: cytoarchitectural determinants of epidermal morphogenesis.

Authors:  Cory L Simpson; Dipal M Patel; Kathleen J Green
Journal:  Nat Rev Mol Cell Biol       Date:  2011-08-23       Impact factor: 94.444

7. 

Authors:  Elissa M Abrams; Leslie Rourke; Denis Leduc; Patricia Li
Journal:  Can Fam Physician       Date:  2020-05       Impact factor: 3.275

Review 8.  A modular view of cytokine networks in atopic dermatitis.

Authors:  Irit Carmi-Levy; Bernhard Homey; Vassili Soumelis
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

9.  PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis Models.

Authors:  Travis P Barr; Chris Garzia; Srijoy Guha; Elizabeth K Fletcher; Nga Nguyen; Adam J Wieschhaus; Lluis Ferrer; Lidija Covic; Athan Kuliopulos
Journal:  J Invest Dermatol       Date:  2018-10-01       Impact factor: 8.551

10.  Epicutaneous sensitization results in IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis.

Authors:  Lisa M Bartnikas; Michael F Gurish; Oliver T Burton; Sabine Leisten; Erin Janssen; Hans C Oettgen; Jacqueline Beaupré; Christopher N Lewis; K Frank Austen; Stephanie Schulte; Jason L Hornick; Raif S Geha; Michiko K Oyoshi
Journal:  J Allergy Clin Immunol       Date:  2013-02       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.